The LA Times recently published a fairly negative appraisal of the construct of preclinical Alzheimer’s disease (AD). The article described the recent effort by an international committee to update diagnostic…
阅读更多
Biogen, the maker of aducanumab has announced that it will terminate the Phase 4 trial required by the FDA for aducanumab, the monoclonal antibody against beta amyloid that received accelerated…
阅读更多
The medications have not been widely tested in Black people with the disease, underscoring stark — and persistent — disparities ABINGTON, Pa. — Wrapped in a purple blanket, Robert Williford…
阅读更多
Black people know intrinsically about the myriad of life areas negatively impacted by the fact that the myth of white supremacy is baked into the foundations of all American institutions.…
阅读更多
In the first study of its kind in humans, researchers have discovered that it is safe to use sound waves fired into specific areas of the brain to open a…
阅读更多
TAMPA (BLOOM) – Join us as we explore strategies—from mindful living to emerging technologies—and discover how every choice can lead to a longer and healthier life. Welcome to the science of…
阅读更多
UCI MIND Director, Dr. Joshua Grill, is quoted in Neurology Today for his work with colleagues at USC, Massachusetts General Hospital, Brigham and Women’s Hospital, and Eisai on racial and…
阅读更多
Dr. Joshua Grill, Director of UCI MIND is named one of Orange County’s 125 most influential people for 2023 by the Orange County Register! Read article here The post UCI…
阅读更多
UCI MIND faculty members, Drs. Mark Mapstone and Mark Fisher were recently quoted in a recent Rolling Stone article on the political divide between younger voters and aging legislators. Check…
阅读更多
Some people in their 80s and 90s show shockingly little decline in their brainpower. Scientists are beginning to understand what makes them different and how the rest of us might…
阅读更多